CNS5:Pleomorphic xanthoastrocytoma: Difference between revisions
| [unchecked revision] | [unchecked revision] |
| Line 191: | Line 191: | ||
|Specific for PXA, actionable with BRAF/MEK inhibitors; rarely found in diffuse astrocytomas. Favorable prognostic marker (PMID: 35545827). | |Specific for PXA, actionable with BRAF/MEK inhibitors; rarely found in diffuse astrocytomas. Favorable prognostic marker (PMID: 35545827). | ||
|- | |- | ||
| | |TERT | ||
<br /> | <br /> | ||
| | |Promoter mutation | ||
| | |Other | ||
|<span class="blue-text">EXAMPLE:</span> Common (breast cancer) | |<span class="blue-text">EXAMPLE:</span> Common (breast cancer) | ||
|<span class="blue-text">EXAMPLE:</span> P | |<span class="blue-text">EXAMPLE:</span> P | ||